trending Market Intelligence /marketintelligence/en/news-insights/trending/IK_89YkciAmnAne6blaSkA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

S&P puts BioScrip ratings on positive CreditWatch after Option Care merger news

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


S&P puts BioScrip ratings on positive CreditWatch after Option Care merger news

S&P Global Ratings placed the ratings on BioScrip Inc., including the CCC+ issuer credit rating, on CreditWatch with positive implications after the company disclosed plans of a merger with Option Care Enterprises Inc.

The companies agreed to merge to create an independent provider of home and alternate site infusion services in the U.S. healthcare market.

Denver-based BioScrip is a provider of infusion and home care management solutions in the U.S. Option Care is a provider of home and alternate treatment site infusion services for acute and chronic patients in the U.S.

S&P Global Ratings said in its March 20 ratings release that it expects the merged entity to have a leading market share with just over 20% of the U.S. home infusion market, in a relatively fragmented landscape of competitors.

In addition, the rating agency expects the merger will generate material synergies and cost savings, and that the combined company will benefit from a stronger competitive position and a more diversified payor mix.

S&P Global Ratings said the CreditWatch placements on the issue ratings reflect its expectation that they will likely improve, subject to a review of the ultimate capital structure, including the proportion of secured and unsecured debt in the capital structure, the presence of any cross guarantees or structural subordination.

This article was published by S&P Global Market Intelligence and not by S&P Global Ratings, which is a separately managed division of S&P Global.